Dickinsonfaircloth6517

5%) E. coli strains were multidrug-resistant. rmtB gene was detected in all Aminoglycoside-resistant E. coli, and the ESBL-producing E. coli possessed different CTX-M genes. Similarly, fluoroquinolone-resistant E. coli possessed different qnr genes. On the analysis of the gyrB gene sequence of fluoroquinolone-resistant E. coli, multiple point mutations were revealed. In conclusion, a high prevalence of E. coli with high resistance patterns to antimicrobials was revealed in the current study, in addition to a wide distribution of their resistance determinants. These findings highlight the importance of sheep and goats as reservoirs for the dissemination of MDR E. coli and resistance gene horizontal transfer. © 2020 The Author(s).The application of liquid bacterial consortia to soil under natural conditions may fail due to various environmental constraints. In this study, the suitability and efficiency of compost, biogas slurry, crushed corn cob, and zeolite as carriers to support the survival of plant growth-promoting rhizobacteria (PGPR) and improve the performance of multi-strain bacterial consortia to mitigate the effects of salinity stress on wheat under pot conditions were evaluated. The survival of strains of Pseudomonas putida, Serratia ficaria, and Pseudomonas fluorescens labelled with gusA was evaluated for up to 90 days. Seeds coated with different carrier-based formulations of multi-strain consortia were sown in pots at three different salinity levels (1.53, 10, and 15 dS m-1). Results showed that salinity stress significantly reduced wheat growth, yield, gas exchange, and ionic and biochemical parameter values, but the 1-aminocyclopropane-1-carboxylate (ACC) deaminase-containing multi-strain consortium used mitigated the inhibitory effects of salinity on plant growth and yield parameters. However, carrier-based inoculation further improved the efficacy of multi-strain consortium inoculation and significantly (P  less then  0.05) increased the growth, yield, and physiological parameters value of wheat at all salinity levels. On the basis of the observed trends in survival and the outcomes of the pot trials, the inoculation of multi-strain consortia in compost and biogas slurry carriers resulted in more successful wheat growth under salinity stress compared to that in the rest of the treatments tested. © 2019 The Author(s).Ceylon Spinach (Basella albe) is an edible perennial vine found in tropical Asia and Africa, known as vegetables containing mucilage. Its mucilage from flowers was extracted by microwaving and precipitated with 95% ethanol. Five artificial saliva formulations composing of mucilage from Ceylon Spinach, calcium chloride (CaCl2), potassium chloride (KCl) and sodium fluoride (NF) were developed. The best formulation No.5 containing 0.61% of the mucilage with the non-Newtonian pseudoplastic flow (8.9 ± 0.2 cP) and the wetting time (12.50 ± 2.24 min) similar to the normal human saliva was selected. This artificial saliva formulation exhibited biological activities including an antioxidative activity by DPPH free radical scavenging with the SC50 of 14.26 ± 2.00 mg/ml (0.05 folds of ascorbic acid), and the adhesion inhibition of S. mutans on hydroxyapatite beads at 17.01 ± 7.75%, while the natural human saliva exhibited an increase bacterial adhesion of 33.10 ± 9.70%. The safety of this formulation which gave no cytotoxicity on normal human gingival fibroblasts at 99.20 ± 21.09% cell viability was also demonstrated. The results from this study have indicated high biological activity and safety of the developed formulation containing mucilage from Ceylon Spinach which is potential to be used as artificial saliva for xerostomia patients. © 2020 Published by Elsevier B.V. on behalf of King Saud University.Background For patients with chronic, non-cancer pain, traditional pain-relieving medications include opioids, which have shown benefits but are associated with increased risks of addiction and adverse effects. Medical cannabis has emerged as a treatment alternative for managing these patients and there has been a rise in the number of randomized clinical trials in recent years; therefore, a systematic review of the evidence was warranted. Objective To analyze the evidence surrounding the benefits and harms of medical cannabinoids in the treatment of chronic, non-cancer-related pain. Design Systematic review with meta-analysis. Data sources Medline, Embase, CINAHL, SCOPUS, Google Scholar, and Cochrane Databases. Eligibility criteria English language randomized clinical trials of cannabinoids for the treatment of chronic, non-cancer-related pain. Data extraction and synthesis Study quality was assessed using the Cochrane risk of bias tool. GW4869 nmr All stages were conducted independently by a team of 6 reviewers. Data non-cancer pain at 2 weeks. Similar results were observed at later time points, but the confidence in effect is low. There is little evidence that cannabinoids increase the risk of experiencing serious AEs, although non-serious AEs may be common in the short-term period following use. © The Author(s) 2020.Background Anabolic androgenic steroid (AAS) use is associated with serious mental and physical health problems. Evidence indicates that AAS use among people who use psychoactive substances is higher than in the general population. This study aims to estimate lifetime AAS use among patients in substance use disorder (SUD) treatment, compare characteristics of AAS and non-AAS users and identify whether AAS use was addressed during treatment. Methods This cross-sectional survey included 563 (142 women, 24.2%) patients in 38 SUD treatment facilities in Norway. Respondents reported on AAS and substance use, and treatment experiences. Results Lifetime AAS use was reported by 156 (28.3%) SUD patients, thereof 35.6% of the men and 8.0% of the women. Lifetime AAS use was highest among men with stimulants (55.8%) as preferred substance, and lowest among men who preferred alcohol (14.6%). Initiation of AAS use due to getting thinner following substance use was reported by 44.5% of the AAS using men. AAS users reported more severe substance use than non-AAS users.